Skip to main content
Erschienen in: Quality of Life Research 10/2009

01.12.2009

Development and validation of a composite score based on clinically meaningful events for the opioid-related symptom distress scale

verfasst von: Kitty S. Chan, Wen-Hung Chen, T. J. Gan, Ray Hsieh, Connie Chen, Mani Lakshminarayanan, Dennis A. Revicki

Erschienen in: Quality of Life Research | Ausgabe 10/2009

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To develop and validate a composite score based on clinically meaningful events (CMEs) for the opioid-related symptom distress scale (OR-SDS) that would be appropriate for use in postoperative clinical trials.

Methods

Secondary analysis of data from 2 multi-site Phase III randomized clinical safety trials: a general surgery trial (N = 1,050) and a coronary artery bypass graft surgery trial (N = 1,636). Validating measures include daily opioid consumption and physician and patient global evaluations of study medication. We empirically defined CMEs for each symptom, using factor analysis and an area under the receiver-operating characteristic analysis of the severity and frequency items of the OR-SDS. Construct validity was examined by testing hypotheses of relationships between composite CME scores and opioid consumption and physician and patient evaluations of study medication.

Results

Hypotheses supporting the construct validity of the CME-based composite score were confirmed. Significant associations were found between higher numbers of CMEs with greater opioid consumption and lower likelihood of a positive evaluation of the study medication.

Conclusions

The OR-SDS CME-based composite score demonstrates evidence of construct validity and appears appropriate for use in evaluating patients’ opioid-related side effect burden in future postoperative clinical trials.
Literatur
1.
Zurück zum Zitat Wheeler, M., Oderda, G. M., Ashburn, M. A., & Lipman, A. G. (2002). Adverse events associated with postoperative opioid analgesia: A systematic review. The Journal of Pain, 3(3), 159–180.CrossRefPubMed Wheeler, M., Oderda, G. M., Ashburn, M. A., & Lipman, A. G. (2002). Adverse events associated with postoperative opioid analgesia: A systematic review. The Journal of Pain, 3(3), 159–180.CrossRefPubMed
2.
Zurück zum Zitat Aubrun, F., Monsel, S., Langeron, O., Coriat, P., & Riou, B. (2001). Postoperative titration of intravenous morphine. European Journal of Anaesthesiology, 18(3), 159–165.PubMed Aubrun, F., Monsel, S., Langeron, O., Coriat, P., & Riou, B. (2001). Postoperative titration of intravenous morphine. European Journal of Anaesthesiology, 18(3), 159–165.PubMed
3.
Zurück zum Zitat Keita, H., Geachan, N., Dahmani, S., Couderc, E., Armand, C., Quazza, M., et al. (2003). Comparison between patient-controlled analgesia and subcutaneous morphine in elderly patients after total hip replacement. British Journal of Anaesthesia, 90(1), 53–57.CrossRefPubMed Keita, H., Geachan, N., Dahmani, S., Couderc, E., Armand, C., Quazza, M., et al. (2003). Comparison between patient-controlled analgesia and subcutaneous morphine in elderly patients after total hip replacement. British Journal of Anaesthesia, 90(1), 53–57.CrossRefPubMed
4.
Zurück zum Zitat Zhao, S. Z., Chung, F., Hanna, D. B., Raymundo, A. L., Cheung, R. Y., & Chen, C. (2004). Dose-response relationship between opioid use and adverse effects after ambulatory surgery. Journal of Pain and Symptom Management, 28(1), 35–46.CrossRefPubMed Zhao, S. Z., Chung, F., Hanna, D. B., Raymundo, A. L., Cheung, R. Y., & Chen, C. (2004). Dose-response relationship between opioid use and adverse effects after ambulatory surgery. Journal of Pain and Symptom Management, 28(1), 35–46.CrossRefPubMed
5.
Zurück zum Zitat Zaheer, S., Reilly, W. T., Pemberton, J. H., & Ilstrup, D. (1998). Urinary retention after operations for benign anorectal diseases. Diseases of the Colon and Rectum, 41(6), 696–704.CrossRefPubMed Zaheer, S., Reilly, W. T., Pemberton, J. H., & Ilstrup, D. (1998). Urinary retention after operations for benign anorectal diseases. Diseases of the Colon and Rectum, 41(6), 696–704.CrossRefPubMed
6.
Zurück zum Zitat Apfelbaum, J. L., Gan, T. J., Zhao, S., Hanna, D. B., & Chen, C. (2004). Reliability and validity of the perioperative opioid-related symptom distress scale. Anesthesia and Analgesia, 99(3), 699–709. (Table of contents).CrossRefPubMed Apfelbaum, J. L., Gan, T. J., Zhao, S., Hanna, D. B., & Chen, C. (2004). Reliability and validity of the perioperative opioid-related symptom distress scale. Anesthesia and Analgesia, 99(3), 699–709. (Table of contents).CrossRefPubMed
7.
Zurück zum Zitat Given, B., Given, C. W., Sikorskii, A., Jeon, S., McCorkle, R., Champion, V., et al. (2008). Establishing mild, moderate, and severe scores for cancer-related symptoms: how consistent and clinically meaningful are interference-based severity cut-points? Journal of Pain and Symptom Management, 35(2), 126–135.CrossRefPubMed Given, B., Given, C. W., Sikorskii, A., Jeon, S., McCorkle, R., Champion, V., et al. (2008). Establishing mild, moderate, and severe scores for cancer-related symptoms: how consistent and clinically meaningful are interference-based severity cut-points? Journal of Pain and Symptom Management, 35(2), 126–135.CrossRefPubMed
8.
Zurück zum Zitat Nussmeier, N. A., Whelton, A. A., Brown, M. T., Joshi, G. P., Langford, R. M., Singla, N. K., et al. (2006). Safety and efficacy of the cyclooxygenase-2 inhibitors parecoxib and valdecoxib after noncardiac surgery. Anesthesiology, 104(3), 518–526.CrossRefPubMed Nussmeier, N. A., Whelton, A. A., Brown, M. T., Joshi, G. P., Langford, R. M., Singla, N. K., et al. (2006). Safety and efficacy of the cyclooxygenase-2 inhibitors parecoxib and valdecoxib after noncardiac surgery. Anesthesiology, 104(3), 518–526.CrossRefPubMed
9.
Zurück zum Zitat Ott, E., Nussmeier, N. A., Duke, P. C., Feneck, R. O., Alston, R. P., Snabes, M. C., et al. (2003). Efficacy and safety of the cyclooxygenase 2 inhibitors parecoxib and valdecoxib in patients undergoing coronary artery bypass surgery. Journal of Thoracic and Cardiovascular Surgery, 125(6), 1481–1492.CrossRefPubMed Ott, E., Nussmeier, N. A., Duke, P. C., Feneck, R. O., Alston, R. P., Snabes, M. C., et al. (2003). Efficacy and safety of the cyclooxygenase 2 inhibitors parecoxib and valdecoxib in patients undergoing coronary artery bypass surgery. Journal of Thoracic and Cardiovascular Surgery, 125(6), 1481–1492.CrossRefPubMed
10.
Zurück zum Zitat Portenoy, R. K., Thaler, H. T., Kornblith, A. B., Lepore, J. M., Friedlander-Klar, H., Kiyasu, E., et al. (1994). The Memorial Symptom Assessment Scale: An instrument for the evaluation of symptom prevalence, characteristics and distress. European Journal of Cancer, 30A(9), 1326–1336.CrossRefPubMed Portenoy, R. K., Thaler, H. T., Kornblith, A. B., Lepore, J. M., Friedlander-Klar, H., Kiyasu, E., et al. (1994). The Memorial Symptom Assessment Scale: An instrument for the evaluation of symptom prevalence, characteristics and distress. European Journal of Cancer, 30A(9), 1326–1336.CrossRefPubMed
11.
Zurück zum Zitat Portenoy, R. K., Thaler, H. T., Kornblith, A. B., Lepore, J. M., Friedlander-Klar, H., Coyle, N., et al. (1994). Symptom prevalence, characteristics and distress in a cancer population. Quality of Life Research, 3(3), 183–189.CrossRefPubMed Portenoy, R. K., Thaler, H. T., Kornblith, A. B., Lepore, J. M., Friedlander-Klar, H., Coyle, N., et al. (1994). Symptom prevalence, characteristics and distress in a cancer population. Quality of Life Research, 3(3), 183–189.CrossRefPubMed
12.
Zurück zum Zitat Jöreskog, K. G., & Sörbom, D. (1985). LISREL VI: Analysis of linear structural relationships by maximum likelihood, instrumental variables, and least squares. Uppsala, Sweden: University of Uppsala. Jöreskog, K. G., & Sörbom, D. (1985). LISREL VI: Analysis of linear structural relationships by maximum likelihood, instrumental variables, and least squares. Uppsala, Sweden: University of Uppsala.
13.
Zurück zum Zitat Bentler, P. M. (1989). EQS, structural equations: Program manual, program version 3.0. Los Angeles: BMDP Statistical Software, Inc. Bentler, P. M. (1989). EQS, structural equations: Program manual, program version 3.0. Los Angeles: BMDP Statistical Software, Inc.
14.
Zurück zum Zitat Gan, T. J., Joshi, G. P., Zhao, S. Z., Hanna, D. B., Cheung, R. Y., & Chen, C. (2004). Presurgical intravenous parecoxib sodium and follow-up oral valdecoxib for pain management after laparoscopic cholecystectomy surgery reduces opioid requirements and opioid-related adverse effects. Acta Anaesthesiologica Scandinavica, 48(9), 1194–1207.CrossRefPubMed Gan, T. J., Joshi, G. P., Zhao, S. Z., Hanna, D. B., Cheung, R. Y., & Chen, C. (2004). Presurgical intravenous parecoxib sodium and follow-up oral valdecoxib for pain management after laparoscopic cholecystectomy surgery reduces opioid requirements and opioid-related adverse effects. Acta Anaesthesiologica Scandinavica, 48(9), 1194–1207.CrossRefPubMed
15.
Zurück zum Zitat Hanley, J. A., & McNeil, B. J. (1982). The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology, 143(1), 29–36.PubMed Hanley, J. A., & McNeil, B. J. (1982). The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology, 143(1), 29–36.PubMed
16.
Zurück zum Zitat Hanley, J. A., & McNeil, B. J. (1983). A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology, 148(3), 839–843.PubMed Hanley, J. A., & McNeil, B. J. (1983). A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology, 148(3), 839–843.PubMed
17.
Zurück zum Zitat Diggle, P. J., Liang, K. Y., & Zeger, S. L. (1994). Analysis of longitudinal data. Oxford, UK: Clarendon Press. Diggle, P. J., Liang, K. Y., & Zeger, S. L. (1994). Analysis of longitudinal data. Oxford, UK: Clarendon Press.
18.
Zurück zum Zitat Shen, J., Barbera, J., & Shapiro, C. M. (2006). Distinguishing sleepiness and fatigue: focus on definition and measurement. Sleep Medicine Reviews, 10(1), 63–76.CrossRefPubMed Shen, J., Barbera, J., & Shapiro, C. M. (2006). Distinguishing sleepiness and fatigue: focus on definition and measurement. Sleep Medicine Reviews, 10(1), 63–76.CrossRefPubMed
Metadaten
Titel
Development and validation of a composite score based on clinically meaningful events for the opioid-related symptom distress scale
verfasst von
Kitty S. Chan
Wen-Hung Chen
T. J. Gan
Ray Hsieh
Connie Chen
Mani Lakshminarayanan
Dennis A. Revicki
Publikationsdatum
01.12.2009
Verlag
Springer Netherlands
Erschienen in
Quality of Life Research / Ausgabe 10/2009
Print ISSN: 0962-9343
Elektronische ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-009-9547-2

Weitere Artikel der Ausgabe 10/2009

Quality of Life Research 10/2009 Zur Ausgabe